R.H. Bluestein & Co’s Amphastar Pharmaceuticals AMPH Stock Holding History

R.H. Bluestein & Co’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$351K	Hold	12,500	–	–	0.02%	203
2022 Q2	$435K	Hold	12,500	–	–	0.03%	180
2022 Q1	$449K	Hold	12,500	–	–	0.02%	211
2021 Q4	$291K	Hold	12,500	–	–	0.01%	325
2021 Q3	$238K	Hold	12,500	–	–	0.01%	366
2021 Q2	$252K	Hold	12,500	–	–	0.01%	362
2021 Q1	$229K	Hold	12,500	–	–	0.01%	371
2020 Q4	$251K	Sell	12,500 -2,500	-17%	-$48.6K	0.01%	323
2020 Q3	$281K	Hold	15,000	–	–	0.01%	258
2020 Q2	$337K	Hold	15,000	–	–	0.02%	212
2020 Q1	$223K	Hold	15,000	–	–	0.02%	232
2019 Q4	$289K	Hold	15,000	–	–	0.01%	284
2019 Q3	$297K	Hold	15,000	–	–	0.02%	251
2019 Q2	$317K	Hold	15,000	–	–	0.02%	224
2019 Q1	$306K	Hold	15,000	–	–	0.02%	212
2018 Q4	$299K	Hold	15,000	–	–	0.02%	184
2018 Q3	$289K	Hold	15,000	–	–	0.01%	258
2018 Q2	$229K	Hold	15,000	–	–	0.01%	287
2018 Q1	$281K	Hold	15,000	–	–	0.02%	260
2017 Q4	$289K	Hold	15,000	–	–	0.02%	250
2017 Q3	$268K	Hold	15,000	–	–	0.01%	267
2017 Q2	$268K	Sell	15,000 -5,000	-25%	-$79.3K	0.02%	244
2017 Q1	$290K	Hold	20,000	–	–	0.02%	247
2016 Q4	$368K	Hold	20,000	–	–	0.02%	171
2016 Q3	$379K	Hold	20,000	–	–	0.02%	146
2016 Q2	$322K	Buy	+20,000	New	+$282K	0.02%	170

Other funds holding AMPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

R.H. Bluestein & Co's AMPH Position: Q3 2022 in Review

R.H. Bluestein & Co held its Amphastar Pharmaceuticals (AMPH) position steady in Q3 2022 at 12,500 shares worth $351K. The position accounts for 0.02% of the portfolio, ranked #203.

R.H. Bluestein & Co first reported a position in AMPH in Q2 2016 and has held it in 26 quarters since. The position peaked at $449K in Q1 2022. 207 funds tracked by Wall St. Rank hold AMPH as of Q3 2022.

R.H. Bluestein & Co held 12,500 shares of Amphastar Pharmaceuticals worth $351K as of Q3 2022.
R.H. Bluestein & Co left its Amphastar Pharmaceuticals share count unchanged in Q3 2022.
Amphastar Pharmaceuticals made up 0.02% of R.H. Bluestein & Co's portfolio in Q3 2022, its #203 holding.
R.H. Bluestein & Co first reported a position in Amphastar Pharmaceuticals in Q2 2016 and has held it in 26 quarters since.
R.H. Bluestein & Co's Amphastar Pharmaceuticals position peaked at $449K in Q1 2022.
207 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2022.

Based on R.H. Bluestein & Co's 13F filing for Q3 2022, filed 14 Nov 2022.